Translational Control of Immune Evasion in Cancer: Trends in Cancer

Por um escritor misterioso

Descrição

Translational Control of Immune Evasion in Cancer: Trends in Cancer
Mechanisms of Tumor Cell–Intrinsic Immune Evasion
Translational Control of Immune Evasion in Cancer: Trends in Cancer
A membrane-associated MHC-I inhibitory axis for cancer immune
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Cancers, Free Full-Text
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Obstacles for T-lymphocytes in the tumour microenvironment
Translational Control of Immune Evasion in Cancer: Trends in Cancer
PD-L1-mediated immune evasion in triple-negative breast cancer is
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Frontiers Therapeutic strategies for gastric cancer targeting
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Combination cancer immunotherapies: Emerging treatment strategies
Translational Control of Immune Evasion in Cancer: Trends in Cancer
The cancer immunity cycle. Diagram illustrating the seven major
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Macrophage CD5L is a target for cancer immunotherapy - eBioMedicine
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Frontiers Molecular mechanisms of immunotherapy resistance in
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Breast cancers co-opt normal mechanisms of tolerance to promote
de por adulto (o preço varia de acordo com o tamanho do grupo)